Sanolla
Cardiopulmonary Diagnosis, Monitoring, and Screening
Company Overview
Snapshot
Founded in April 2016 by Doron Adler and Dudu Linhard, Sanolla operates with 11–50 employees. The company has raised a total of $16 million across 6 funding rounds from 4 investors.
Business overview
Sanolla is a Health Tech & Life Sciences company specializing in smart diagnostic solutions for the early assessment and monitoring of cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, and COVID-19. The company's core technology leverages AI-powered detection and analysis of body infrasounds and other vital signs like ECG, heart rate, oxygen level, body temperature, and respiratory cycle. Sanolla's products, including VoqX, SonoX, and PyXy, aim to provide immediate and accurate assessments, reducing the need for in-clinic visits and lowering infection exposure risks. It serves the Digital Healthcare sector, specifically Digital Medical Diagnostics and Patient Remote Monitoring, targeting healthcare providers and patients in geomarkets including North America, Europe, and Southeast Asia.
Strategic signal
In September 2025, Sanolla is set to launch its VoqX smart stethoscope, which offers full-spectrum auscultation and is powered by AI. This upcoming product launch indicates a significant advancement in diagnostic tools, positioning Sanolla as a leader in integrating artificial intelligence with medical devices to enhance clinical practice and potentially improve early detection and monitoring of cardiopulmonary conditions.
Log in to access full profile ›Company Intelligence Q&A
- What is Sanolla's primary focus?
- Sanolla focuses on providing smart diagnostic solutions for the early assessment and monitoring of cardiopulmonary conditions, utilizing AI-powered detection of body infrasounds and other vital signs.
- When was Sanolla founded and by whom?
- Sanolla was founded in April 2016 by Doron Adler and Dudu Linhard.
- What is the key technology behind Sanolla's products?
- Sanolla's products are based on AI-powered detection and analysis of previously inaccessible body infrasounds, combined with other vital signs such as ECG, heart rate, oxygen level, body temperature, and respiratory cycle.
- What significant product launch is Sanolla planning?
- In September 2025, Sanolla is launching its VoqX smart stethoscope, which features AI-powered full-spectrum auscultation.